123 related articles for article (PubMed ID: 37336688)
61. Bee's honey attenuates non-alcoholic steatohepatitis-induced hepatic injury through the regulation of thioredoxin-interacting protein-NLRP3 inflammasome pathway.
Xiao J; Liu Y; Xing F; Leung TM; Liong EC; Tipoe GL
Eur J Nutr; 2016 Jun; 55(4):1465-77. PubMed ID: 26133299
[TBL] [Abstract][Full Text] [Related]
62. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade.
Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323
[TBL] [Abstract][Full Text] [Related]
63. PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice.
Sun CC; Zhang CY; Duan JX; Guan XX; Yang HH; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX; Liu SK; Zhang J
Biochem Biophys Res Commun; 2020 Mar; 523(4):1020-1026. PubMed ID: 31973813
[TBL] [Abstract][Full Text] [Related]
64. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
[TBL] [Abstract][Full Text] [Related]
65. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
[TBL] [Abstract][Full Text] [Related]
66. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
[TBL] [Abstract][Full Text] [Related]
67. Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.
Wang PX; Zhang XJ; Luo P; Jiang X; Zhang P; Guo J; Zhao GN; Zhu X; Zhang Y; Yang S; Li H
Nat Commun; 2016 Feb; 7():10592. PubMed ID: 26882989
[TBL] [Abstract][Full Text] [Related]
68. Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway.
Yan BF; Wang Y; Wang WB; Ding XJ; Wei B; Liu SJ; Fu TM; Chen L; Zhang JZ; Liu J; Zheng X
J Ethnopharmacol; 2023 Mar; 303():115999. PubMed ID: 36509260
[TBL] [Abstract][Full Text] [Related]
69. Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.
Wang S; Yan ZZ; Yang X; An S; Zhang K; Qi Y; Zheng J; Ji YX; Wang PX; Fang C; Zhu XY; Shen LJ; Yan FJ; Bao R; Tian S; She ZG; Tang YD
Hepatology; 2018 Apr; 67(4):1320-1338. PubMed ID: 29077210
[TBL] [Abstract][Full Text] [Related]
70. NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice.
Wang X; Sun K; Zhou Y; Wang H; Zhou Y; Liu S; Nie Y; Li Y
Biochem Biophys Res Commun; 2021 Jan; 534():734-739. PubMed ID: 33213837
[TBL] [Abstract][Full Text] [Related]
71. Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis.
Xiao XH; Wang YD; Qi XY; Wang YY; Li JY; Li H; Zhang PY; Liao HL; Li MH; Liao ZZ; Yang J; Xu CX; Wen GB; Liu JH
Int J Obes (Lond); 2018 Aug; 42(8):1418-1430. PubMed ID: 30006580
[TBL] [Abstract][Full Text] [Related]
72. Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease.
Lee KC; Hsieh YC; Chan CC; Sun HJ; Huang YH; Hou MC; Lin HC
Lab Invest; 2019 Jul; 99(8):1203-1216. PubMed ID: 30918325
[TBL] [Abstract][Full Text] [Related]
73. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.
Wilson CG; Tran JL; Erion DM; Vera NB; Febbraio M; Weiss EJ
Endocrinology; 2016 Feb; 157(2):570-85. PubMed ID: 26650570
[TBL] [Abstract][Full Text] [Related]
74. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway.
Li M; Xu C; Shi J; Ding J; Wan X; Chen D; Gao J; Li C; Zhang J; Lin Y; Tu Z; Kong X; Li Y; Yu C
Gut; 2018 Dec; 67(12):2169-2180. PubMed ID: 28877979
[TBL] [Abstract][Full Text] [Related]
75. Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease.
Wang H; Zhao Y; Pan Y; Yang A; Li C; Wang S; Dong Z; Li M; Wang S; Zhang Z; Zhu Y; Zhang D; Sun G
JHEP Rep; 2023 Jun; 5(6):100726. PubMed ID: 37138676
[TBL] [Abstract][Full Text] [Related]
76. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
77. Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene.
Zhao ZH; Wang ZX; Zhou D; Han Y; Ma F; Hu Z; Xin FZ; Liu XL; Ren TY; Zhang F; Xue Y; Cui A; Liu Z; Bai J; Liu Y; Cai G; Su W; Dai X; Shen F; Pan Q; Li Y; Fan JG
Cell Mol Gastroenterol Hepatol; 2021; 12(3):857-871. PubMed ID: 33989817
[TBL] [Abstract][Full Text] [Related]
78. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
Takahara I; Akazawa Y; Tabuchi M; Matsuda K; Miyaaki H; Kido Y; Kanda Y; Taura N; Ohnita K; Takeshima F; Sakai Y; Eguchi S; Nakashima M; Nakao K
PLoS One; 2017; 12(3):e0170591. PubMed ID: 28278289
[TBL] [Abstract][Full Text] [Related]
79. PI3K inhibition protects mice from NAFLD by down-regulating CMKLR1 and NLRP3 in Kupffer cells.
Zhang W; Liu Y; Wu M; Zhu X; Wang T; He K; Li P; Wu X
J Physiol Biochem; 2017 Nov; 73(4):583-594. PubMed ID: 28905319
[TBL] [Abstract][Full Text] [Related]
80. Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis.
Winther-Sørensen M; Galsgaard KD; Santos A; Trammell SAJ; Sulek K; Kuhre RE; Pedersen J; Andersen DB; Hassing AS; Dall M; Treebak JT; Gillum MP; Torekov SS; Windeløv JA; Hunt JE; Kjeldsen SAS; Jepsen SL; Vasilopoulou CG; Knop FK; Ørskov C; Werge MP; Bisgaard HC; Eriksen PL; Vilstrup H; Gluud LL; Holst JJ; Wewer Albrechtsen NJ
Mol Metab; 2020 Dec; 42():101080. PubMed ID: 32937194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
